New Lupus Drug Shows Promise
Links shared publicly online about this topic
New lupus drug shows promise in trial – The CNN Wire - CNN.com Blogs
cnnwire.blogs.cnn.com — “New lupus drug shows promise in trial – The CNN Wire - CNN.com Blogs” View full resource at cnnwire.blogs.cnn.com
Most Recently Shared on July 23, 2009 at 4:27 pm By:
CNN interviews Lupus Research Institute president Margaret Dowd about Benlysta: http://ow.ly/i0Bx
Benlysta Shows Promise for Lupus
lupus.webmd.com — “People with lupus given the first in a new class of experimental drugs that targets the disease process did better than those given standard treatment, according to one-year results of a large clinical trial.” View full resource at lupus.webmd.com
Most Recently Shared on November 15, 2010 at 7:26 pm By:
Benlysta Shows Promise for Lupus: People with lupus given the first in a new class of experimental drugs that ta... http://bit.ly/cc1MOS
Lupus drug Benlysta shows promise, company says - USATODAY.com
rssfeeds.usatoday.com — “An experimental lupus drug that produced favorable results in a company-backed study has prompted its makers on Monday to tout the drug as potentially the first new drug for lupus in half a century.” View full resource at rssfeeds.usatoday.com
Most Recently Shared on July 20, 2009 at 5:07 am By:
Lupus drug Benlysta shows promise, company says http://tr.im/t6RI
UPDATE 3-Immunomedics soars as lupus drug shows promise | Reuters
reuters.com — “* Positive Phase IIb results for UCB, Immunomedics drug * Treatment advantage of epratuzumab vs placebo 24.9 pct * Analysts say result promising but drug still high risk * Immunomedics shares up” View full resource at reuters.com
Most Recently Shared on August 27, 2009 at 3:44 pm By:
Immunomedics lupus drug shows promise; Positive Phase IIb results for epratuzumab http://ow.ly/lyNt
UPDATE 3-Immunomedics soars as lupus drug shows promise | Reuters
reuters.com — “* Positive Phase IIb results for UCB, Immunomedics drug * Treatment advantage of epratuzumab vs placebo 24.9 pct * Analysts say result promising but drug still high risk * Immunomedics shares up” View full resource at reuters.com
Most Recently Shared on August 27, 2009 at 8:25 am By:
UCB and Immunomedics clear Phase II lupus hurdle - but can they repeat Human Genome's Phase III success? http://tinyurl.com/kuyzw6
Epratuzumab, New Drug In Development For Systemic Lupus Erythamatosus Enters Phase III Trials After Promising Results In A Smaller Study
medicalnewstoday.com — “For the past 50 years there have been no new drug treatments approved for systemic lupus erythamatosus (SLE). Now, at last, that situation could soon change. The FDA is currently reviewing one ne” View full resource at medicalnewstoday.com
Most Recently Shared on November 15, 2010 at 4:12 pm By:
Epratuzumab, New Drug In Development For Systemic Lupus Erythamatosus Enters Phase III Trials After Promising Resul... http://sns.ly/dtW62
Lupus Drug Shows Promising Results - WSJ.com
online.wsj.com — “Human Genome and GlaxoSmithKline said their experimental drug Benlysta met the goal of a second late-stage study in treating lupus, making it likely to be the first treatment in decades for the hard-to-treat autoimmune disease.” View full resource at online.wsj.com
Most Recently Shared on November 2, 2009 at 9:58 am By:
Lupus Drug Shows Promising Results - WSJ.com
online.wsj.com — “Human Genome and GlaxoSmithKline said their experimental drug Benlysta met the goal of a second late-stage study in treating lupus, making it likely to be the first treatment in decades for the hard-to-treat autoimmune disease.” View full resource at online.wsj.com
Most Recently Shared on November 2, 2009 at 2:03 pm By:
New Lupus Drug Advances, Raising a Company's Hopes - NYTimes.com
nytimes.com — “Human Genome Sciences said early Monday that its experimental drug to treat lupus was effective in its second big clinical trial.” View full resource at nytimes.com
Most Recently Shared on November 2, 2009 at 4:27 pm By:
Cancer drug shows promise for treating a wide range of inflammatory diseases
physorg.com — “Those looking for a new treatment for a range of inflammatory diseases like arthritis, multiple sclerosis, inflammatory bowel disease, and lupus may need to look no further than a drug already available for treating cancer. In a research report published in the July 2010 print issue of the Journal of ...” View full resource at physorg.com
Most Recently Shared on June 30, 2010 at 3:22 pm By:
Cancer drug shows promise for treating a wide range of inflammatory diseases http://bit.ly/blxAzt
Cancer drug shows promise for treating a wide range of inflammatory diseases
eurekalert.org — “Those looking for a new treatment for a range of inflammatory diseases like arthritis, multiple sclerosis, inflammatory bowel disease, and lupus may need to look no further than a drug already available for treating cancer. In a research report published in the July 2010 print issue of the Journal of Leukocyte Biology, Japanese scientists use mice to show that bortezomib induces cell death only in harmful (active and proliferating) T cells, leaving the rest unharmed.” View full resource at eurekalert.org
Most Recently Shared on July 1, 2010 at 10:00 pm By:
#Cancer drug shows promise for treating a wide range of inflammatory diseases. http://eurekalert.org/e/3Wgr #EurekAlert
New Migraine Drug Shows Promise
health.msn.com — “New Migraine Drug Shows Promise” View full resource at health.msn.com
Most Recently Shared on August 14, 2009 at 7:32 pm By:
Suicide Is Surprise In FDA Review Of Lupus Drug - Matthew Herper - The Medicine Show - Forbes
blogs.forbes.com — “The Food and Drug Administration released its review of the data supporting the approval of Benlysta, the lupus treatment being developed by Human Genome Sciences and GlaxoSmithKline, this morning. The FDA's briefing documents will serve as the basis for a discussion by a panel of experts on November 16. Analysts [...]” View full resource at blogs.forbes.com
Most Recently Shared on November 12, 2010 at 4:28 pm By:
Suicide Is Surprise In FDA Review Of Lupus Drug: A new worry crops up for a promising drug. http://bit.ly/bMsimC #drug
Cancer drug shows promise for treating a wide range of inflammatory diseases | e! Science News
esciencenews.com — “Those looking for a new treatment for a range of inflammatory diseases like arthritis, multiple sclerosis, inflammatory bowel disease, and lupus may need to look no further than a drug already available for treating cancer. In a research report published in the July 2010 print issue of the Journal of Leukocyte Biology ( http://www.jleukbio.org ), Japanese scientists use mice to show that bortezomib, currently used to tr” View full resource at esciencenews.com
Most Recently Shared on July 1, 2010 at 6:00 pm By:
Cancer drug shows promise for treating a wide range of inflammatory diseases http://esciencenews.com/node/333253
New Rheumatoid Arthritis Drug Shows Promise in Study
healthcentral.com — “New Rheumatoid Arthritis Drug Shows Promise in Study” View full resource at healthcentral.com
Most Recently Shared on May 17, 2010 at 8:32 pm By:
New #RheumatoidArthritis Drug Shows Promise in Study: http://bit.ly/bDhJGj
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
LRI
The world's leading nonprofit singularly dedicated to novel research in lupus.
-
WebMD_News
The leading source for trustworthy and timely health news and information.
-
Maureen Linke
USA TODAY Your Life, including news on health, fitness, food, parenting, family, pets, aging, sex, relationships, self-improvement and body image (web producer)
Advertisement

